|
Market Closed -
Nasdaq Helsinki
20:00:00 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.368 EUR | +1.18% |
|
-1.44% | -63.71% |
| 08-14 | Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-14 | Optomed Oyj Provides Earnings Guidance for the Year 2026 | CI |
| Market Cap | 29.03M 32.41M 26.78M 24.24M 45.32M 3.09B 46.06M 320M 127M 1.62B 122M 119M 5.12B | P/E 2026 * |
-8.72x | P/E 2027 * | -12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 26.03M 29.06M 24.02M 21.73M 40.64M 2.77B 41.3M 287M 114M 1.45B 109M 107M 4.59B | EV / Sales 2026 * |
1.48x | EV / Sales 2027 * | 1.36x |
| Free-Float |
94.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Helsinki
| OPTOMED | Delayed | |
CBOE
| Real-time | ||
CBOE
| Real-time | ||
Deutsche Boerse AG
| 36U0 | Delayed |
| 1 day | +0.07% | ||
| 1 week | -1.44% | ||
| Current month | -9.40% | ||
| 1 month | -10.35% | ||
| 3 months | -14.71% | ||
| 6 months | -36.81% | ||
| Current year | -63.71% |
| 1 week | 1.33 | 1.45 | |
| 1 month | 1.33 | 1.56 | |
| Current year | 1.33 | 4.1 | |
| 1 year | 1.33 | 4.33 | |
| 3 years | 1.33 | 7.74 | |
| 5 years | 1.33 | 12.4 | |
| 10 years | 1.33 | 19.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/10/2023 | |
| Director of Finance/CFO | 42 | 05/08/2022 | |
Petri Huhtinen
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 01/01/2006 | |
| Director/Board Member | 74 | 01/01/2019 | |
| Director/Board Member | 70 | 01/01/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/26/25 A | Free | Chief Financial Officer | 40,000 | 0.2031% | ||
| 9/26/25 A | Free | Executive/Senior Manager | 30,000 | 0.1523% | ||
| 9/26/25 A | Free | Executive/Senior Manager | 20,000 | 0.1016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.18% | -1.44% | -65.15% | -45.06% | 32.36M | ||
| +0.12% | +4.29% | +26.38% | +62.54% | 260B | ||
| +0.36% | +2.29% | +9.81% | +26.96% | 165B | ||
| +0.88% | +1.06% | -16.56% | +73.53% | 154B | ||
| -0.86% | -8.75% | -58.14% | -16.11% | 61.49B | ||
| +2.89% | +4.87% | +14.25% | +51.50% | 52.9B | ||
| +0.70% | +2.71% | -13.09% | -6.29% | 52.84B | ||
| -1.74% | -3.11% | +9.01% | +64.24% | 51.46B | ||
| -0.65% | +3.63% | +25.84% | +78.12% | 51.16B | ||
| +0.16% | +4.59% | +38.74% | +101.32% | 46.85B | ||
| Average | +0.16% | +0.82% | -2.89% | +39.07% | 89.57B | |
| Weighted average by Cap. | +0.25% | +1.41% | +6.72% | +50.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.63M 19.69M 16.27M 14.72M 27.53M 1.87B 27.97M 194M 77.43M 981M 73.88M 72.31M 3.11B | 20.6M 23M 19M 17.2M 32.16M 2.19B 32.68M 227M 90.45M 1.15B 86.31M 84.47M 3.63B |
| Net income | -2.95M -3.29M -2.72M -2.46M -4.61M -314M -4.68M -32.47M -12.95M -164M -12.36M -12.1M -520M | -2.3M -2.57M -2.12M -1.92M -3.59M -245M -3.65M -25.32M -10.1M -128M -9.64M -9.43M -405M |
| Net Debt | -3M -3.35M -2.77M -2.5M -4.68M -319M -4.76M -33.02M -13.17M -167M -12.57M -12.3M -529M | -1M -1.12M -923K -835K -1.56M -106M -1.59M -11.01M -4.39M -55.64M -4.19M -4.1M -176M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | €1.368 | +1.18% | 13,631 |
| 28/10/26 | €1.352 | -1.60% | 52,712 |
| 27/10/26 | €1.374 | -0.58% | 15,442 |
| 26/10/26 | €1.382 | -2.68% | 7,705 |
| 23/10/26 | €1.420 | +2.31% | 12,282 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OPTOMED Stock
Select your edition
All financial news and data tailored to specific country editions

















